A three-day conference about building, developing and operating stroke centers to deliver high quality care, to meet the growing patient demand, and to improve outcomes.
“We are the third largest facility in Carolinas Healthcare System (CHS) with 457 beds located in Concord, North Carolina (www.cmc-northeast.org) Level III Trauma Center, Jeff Gordon Children’s Hospital, Hayes Family Center, numerous spe- cialty units (heart, cancer, neurosciences, medical/behavioral health) We serve as a teaching hospital, offering a Family- Medicine Residency in affiliation with UNC School of Medicine and a sports medicine fellowship through Sports Medicine and Injury Center US News and World Report: Honor Roll for Best Hospitals Thomson Reuters: Top 100 Hospitals for Cardiovascular Services Studer Group: Excellence in Patient Care AACN Beacon Award: Critical Care Excellence Recognition for Medical/Surgical Intensive Care Unit American Heart Association / American Stroke Association: Stroke Gold Plus Performance Achievement Award, American Heart Association Mission: Lifeline Bronze Achievement Award J.D. Power and Associates: Outstanding Inpatient Experience for Maternity Services, Emergency Department, and Inpatient Services PRC Achievement Awards for Overall Quality of Care: Top Performer: Inpatient Maternity Services 5 Star: Outpatient Cardiology, Inpatient Services, Outpatient Radiology, Inpatient Cardiology/Telemetry Inpatient OB/GYN”
Stroke is the No. 3 killer in the United States, and the leading cause of adult disability. With the stroke patient population on the rise, it is imperative for hospitals and health facilities to carefully prepare for and provide optimal care for a disease that threatens such a large share of the population.
~National Stroke Association
Administrative and Clinical Leaders Representing Community Hospitals, Academic Medical Centers, Acute-Trauma Centers, Health Systems, Rehabilitation Hospitals and Long-Term Care Facilities. Primary titles include:
Toshiba America, Inc. (TAI), a subsidiary of Toshiba Corporation, is the holding company for one of the nation’s leading group of high technology companies. TAI oversees several operating companies that together span a diversified range of modern electronics, some conducting research and development, manufacturing, sales and service in its field of expertise. TAI is a subsidiary of Toshiba Corporation, a world-leading diversified manufacturer, solutions provider and marketer of advanced electronic and electrical products and systems. Toshiba was founded in 1875, and today operates a global network of more than 599 consolidated companies, with 200,000 employees worldwide and annual sales surpassing 6.5 trillion yen (US$63 billion).
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 35 years. Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. We are among the world’s leading biotech companies, with multiple products on the market and a promising development pipeline. We believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about transforming patients’ lives. We are courageous in both decision and action. And we believe that good business means a better world.
EKR Therapeutics Inc. is a specialty pharmaceutical company focused on identifying, fostering and targeting the growth of products to serve the needs of the acute-care hospital setting. The Company is committed to providing this important segment of the healthcare market with novel products to improve patient outcomes and quality of life.
Stryker is one of the world’s leading medical technology companies and together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes. Stryker is active in over 100 countries around the world.
The National Aphasia Association (NAA) is a non-profit organization founded in 1987 by Martha Taylor Sarno, MA, MD,(hon) as the 1st National organization dedicated to advocating for persons with aphasia and their families. Several of our board members, including the President, are people with Aphasia or family members. Our goal is to provide access to research, education, rehabilitation, therapeutic and advocacy services to individuals with aphasia and their caregivers. The NAA acts as a syndicate of resources, promoting sense of community among individuals and caregivers. NAA is a 501(c)(3) not-for-profit organization.
The North Carolina Stroke Association’s mission is to reduce the incidence and impact of stroke in North Carolina through relationships and collaborations to facilitate screening, education, outcome assessments, and advocacy. NCSA provides assistance with grant writing and mentoring to enable North Carolina’s community hospitals to broaden their reach through Stroke programs and protocols for the hospital and the community-at-large. NCSA is committed to assisting hospitals in their efforts to implement community Stroke prevention and education programs, and to create inpatient Stroke treatment protocols. By focusing on providing standardized program models and grant monies, these goals will be realized throughout North Carolina. The NC Stroke Association is a 501 (c) (3) organization.
The North Carolina Stroke Care Collaborative, formerly know as the NC Collaborative Stroke Registry, is a national effort funded by the CDC to reduce the incidence of death and disability caused by stroke. One of six Paul Coverdell National Acute Stroke Registries, the North Carolina Stroke Care Collaborative assesses the use of best practice guidelines for stroke treatment by conducting real-time data collection on stroke treatment within North Carolina hospitals. Using these data, hospitals are able to measure and improve the quality of patient care.